We are developing a material for use in treating corneal epithelial diseases affecting dogs.
We have already succeeded in the manufacture and clinical application of corneal epithelial cell sheet derived from human amniotic membrane and human corneal epithelial cells. Using the know-how we have obtained from these accomplishments, we plan to launch this new project, targeted at animals.
As a result of the recent pet boom, the number of dogs kept by people is increasing and pet owners are becoming increasingly aware of the importance of healthcare for their pets. Many pet owners actually take care of their pets as if they were their children.
To respond to this trend, medical technology for treating animals is showing great advances as well. The number of veterinary ophthalmologists is also growing.
Although dogs frequently suffer from intractable corneal disorders, it is difficult treat them with corneal transplants because there is no eye bank for dogs. That is why there is growing demand among pet owners and veterinarians for an epoch-making treatment for canine corneal diseases.